Webinar Date/Time: Thu, Oct 12, 2023 2:00 PM EDT
Can your electronic benefit verification system provide patients, healthcare professionals, and office staff with a self-service option that delivers precise financial transparency within seconds?
Register Free: https://www.pharmexec.com/pe_w/driving-patient-affordability
Event Overview:
Fewer than 60% of Pharmacy Benefit Manager (PBM) electronic benefit verifications (eBVs) provide accurate assessments of patients' financial responsibilities, primarily due to the widespread industry practice of relying on artificial intelligence (AI) algorithms for estimation. This inaccuracy has resulted in financial barriers for patients, increased burdens on Patient Assistance Programs (PAP) and Hubs, and hesitance among healthcare providers (HCPs) to prescribe therapy.
In this Pharmaceutical Executive-hosted webinar, EVERSANA's experts, along with a guest speaker, will tackle the obstacles tied to eBV. They will delve into an innovative approach that melds a unique system of product archetypes, proprietary software, automated business logic, and direct, strategic payer relationships to enhance price transparency and grant each stakeholder access to an online, self-service platform.
Key Learning Objectives:
Who Should Attend:
C-Suite, director, senior director, associate director, president, vice president, management with titles: patient services, patient support, patient adherence, patient assistance, patient engagement, patient access, product/brand manager, patient services, patient affordability, market access, specialty, access & reimbursement, brand manager, product manager
Speakers:
Kevin O’Meara
Vice President, Patient Services
EVERSANA
Kevin O’Meara is a patient services leader who is driving change for clients and their patients. With more than 25 years in executive-level leadership roles, he understands the complexities behind access barriers, copay programs and reimbursement, and patient onboarding, as well as how program challenges affect the patient journey. More specifically, his experience focuses on managed care and commercial operations, including copay programs and patient access programs positioned to drive prescription growth. At EVERSANA, Kevin works with clients to pave a pathway for patients and providers to access new and innovative treatments. Kevin has a bachelor’s degree and an MBA from the University of Notre Dame.
Matt Baniak
Vice President, Client & Delivery Excellence
EVERSANA
Matt Baniak currently serves as EVERSANA’s Vice President of Client and Delivery Excellence, a role in which he is responsible for reimbursement HUBs, digital therapies, and complex integrated programs. He also leads EVERSANA’s training, workforce, and customer experience teams. With over 15 years of experience in healthcare leadership, including operations, project management, and analytics, Matt has overseen care teams that include rare exclusive, buy and bill, HUB, and REMs. Additionally, he has worked with GPOs for over 10 years leading operations, analytics, adult learning, and MDM teams. Matt is a graduate of Saint Louis University, where he focused on life sciences and psychology. He currently resides in the Saint Louis metropolitan area with his wife and two children.
Register Free: https://www.pharmexec.com/pe_w/driving-patient-affordability
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
November 14th 2024Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.